Inactive Instrument
Stemcell Holdings, Inc. Stock Other OTC
Stocks
STMM
US85858N2027
Pharmaceuticals
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Masato Ozawa
CEO | Chief Executive Officer | 67 | 24/05/2021 |
Gabriel Garcia
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kato Hirotaro
LAW | General Counsel | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 1.64M | |
| +1.04% | +10.52% | +34.86% | +0.28% | 76.75B | |
| -0.04% | +5.58% | +25.33% | +186.66% | 50.46B | |
| +1.02% | +0.81% | -7.73% | +21.83% | 48.5B | |
| +1.30% | +3.46% | -50.91% | -49.51% | 44.14B | |
| -0.87% | -1.24% | +55.49% | -23.16% | 30.53B | |
| -0.66% | -5.74% | +54.13% | +88.28% | 24.28B | |
| -1.29% | +3.24% | +104.79% | -48.00% | 22.46B | |
| +0.72% | +3.23% | -7.24% | +213.08% | 20.04B | |
| -0.10% | -1.86% | +66.61% | +162.37% | 16.03B | |
| Average | +0.63% | -0.38% | +30.59% | +61.31% | 37.02B | |
| Weighted average by Cap. | +0.72% | +0.67% | +22.86% | +46.65% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 3.34M 2.89M 2.7M 2.48M 4.68M 317M 4.73M 31.68M 12.43M 159M 12.54M 12.26M 526M | 6.18M 5.35M 4.99M 4.59M 8.66M 588M 8.76M 58.63M 23.01M 294M 23.21M 22.7M 974M |
| Net income | 1.4M 1.21M 1.13M 1.04M 1.97M 133M 1.99M 13.31M 5.22M 66.72M 5.27M 5.15M 221M | 2.41M 2.09M 1.95M 1.79M 3.38M 229M 3.42M 22.86M 8.97M 115M 9.05M 8.85M 380M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
